Crossmark

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

Crossref DOI link: https://doi.org/10.1186/s12885-019-5592-6

Published Online: 2019-05-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Georgescu, Constantin

Corbin, Joshua M.

Thibivilliers, Sandra

Webb, Zachary D.

Zhao, Yan D.

Koster, Jan

Fung, Kar-Ming

Asch, Adam S.

Wren, Jonathan D.

Ruiz-Echevarría, Maria J. https://orcid.org/0000-0001-7133-9982
License Information

Text and Data Mining valid from 2019-05-06
More Information

Article History

Received: 15 August 2018

Accepted: 9 April 2019

First Online: 6 May 2019

Ethics approval and consent to participate

: Radical prostatectomy histopathology records from the Department of Pathology at the University of Oklahoma Health Sciences Center were retrospectively examined. The study was approved by the institutional review board of the University of Oklahoma Health Sciences Center (IRB # 6431). The institutional review board issued an expedited review and waived the need for written consent since only archival, de-identified materials were used.

: Not applicable.

: MJRE is an inventor of a pending patent related to this study. It is not commercialized or licensed at this time. The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.